# Amoxicillin Bioequivalence Study Brazil - Fast

> **NCT01431989** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Infections, Bacterial

## Interventions

- **DRUG:** Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL
- **DRUG:** Amoxil® 500mg/5mL powder for oral suspension

## Key facts

- **NCT ID:** NCT01431989
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-27
- **Primary completion:** 2011-06-11
- **Final completion:** 2011-06-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431989, "Amoxicillin Bioequivalence Study Brazil - Fast". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01431989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*